Mesenchymal stem cell therapy may help patients with type 1 or type 2 diabetes optimize their health and experience a better quality of life. Stem cell therapy may decrease hyperglycemia (high blood sugar) and the complications associated with hyperglycemia:
Clinical trials have shown mesenchymal stem cells have the ability to differentiate, self-renew, suppress the immune system, reduce inflammation, and repair tissues. By targeting the cells in the pancreas, and reducing inflammation, stem cell therapy may decrease hyperglycemia and improve the symptoms associated with diabetes.
Mesenchymal stem cells have the ability to:
Diabetes mellitus is a group of diseases that causes a person to have high levels of sugar (glucose) in the blood or hyperglycemia. Diabetes is sometimes referred to as the “silent killer” because it can progress slowly and without warning. It is important for those diagnosed with diabetes to seek treatment early before severe systemic damage has occurred. Stem cell therapy may help patients with diabetes that are not responding adequately to standard drug treatment, are newly diagnosed and would like to try stem cell therapy before initiating drug treatment or would like to reduce the symptoms associated with diabetes.